Posted by Michael Wonder on 22 Feb 2021
EMA publishes agenda for 22-25 February CHMP meeting
22 February 2021 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Abiraterone acetate
- Berotralstat
- Bevacizumab
- Dasatinib monohydrate
- Dostarlimab
